- Home
- MRAM vs RENB Comparison
MRAM vs RENB Comparison
Compare MRAM & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- RENB
- Stock Information
- Founded
- MRAM 2008
- RENB 2011
- Country
- MRAM United States
- RENB United States
- Employees
- MRAM 83
- RENB N/A
- Industry
- MRAM Semiconductors
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- RENB Health Care
- Exchange
- MRAM Nasdaq
- RENB Nasdaq
- Market Cap
- MRAM 130.3M
- RENB 121.3M
- IPO Year
- MRAM 2016
- RENB N/A
- Fundamental
- Price
- MRAM $5.93
- RENB $0.82
- Analyst Decision
- MRAM Strong Buy
- RENB
- Analyst Count
- MRAM 2
- RENB 0
- Target Price
- MRAM $9.00
- RENB N/A
- AVG Volume (30 Days)
- MRAM 83.0K
- RENB 532.2K
- Earning Date
- MRAM 02-26-2025
- RENB 02-19-2025
- Dividend Yield
- MRAM N/A
- RENB N/A
- EPS Growth
- MRAM N/A
- RENB N/A
- EPS
- MRAM 0.07
- RENB N/A
- Revenue
- MRAM $53,865,000.00
- RENB N/A
- Revenue This Year
- MRAM N/A
- RENB N/A
- Revenue Next Year
- MRAM $7.15
- RENB N/A
- P/E Ratio
- MRAM $83.85
- RENB N/A
- Revenue Growth
- MRAM N/A
- RENB N/A
- 52 Week Low
- MRAM $4.89
- RENB $0.40
- 52 Week High
- MRAM $9.39
- RENB $3.38
- Technical
- Relative Strength Index (RSI)
- MRAM 47.32
- RENB 50.63
- Support Level
- MRAM $5.60
- RENB $0.69
- Resistance Level
- MRAM $6.25
- RENB $0.89
- Average True Range (ATR)
- MRAM 0.18
- RENB 0.07
- MACD
- MRAM 0.04
- RENB 0.02
- Stochastic Oscillator
- MRAM 54.93
- RENB 70.41
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.